Pre-order Enquiry
Request Free Sample
Global Anti-Obesity Prescription Market Research Report 2021
SKU ID : QYR-17222079 | Publishing Date : 20-Jan-2021 | No. of pages : 90
Detailed TOC of Global Anti-Obesity Prescription Market Research Report 2021
1 Anti-Obesity Prescription Market Overview1.1 Product Overview and Scope of Anti-Obesity Prescription
1.2 Anti-Obesity Prescription Segment by Type
1.2.1 Global Anti-Obesity Prescription Sales Growth Rate Comparison by Type (2021-2027)
1.2.2 Bupropion and Naltrexone
1.2.3 Orlistat
1.2.4 Lorcaserin
1.2.5 Phentermine and Topiramate
1.2.6 Liraglutide
1.3 Anti-Obesity Prescription Segment by Application
1.3.1 Anti-Obesity Prescription Sales Comparison by Application: (2021-2027)
1.3.2 Hospital Pharmacies
1.3.3 Retail Pharmacies
1.3.4 E-Commerce
1.4 Global Anti-Obesity Prescription Market Size Estimates and Forecasts
1.4.1 Global Anti-Obesity Prescription Revenue 2016-2027
1.4.2 Global Anti-Obesity Prescription Sales 2016-2027
1.4.3 Anti-Obesity Prescription Market Size by Region: 2016 Versus 2021 Versus 2027
2 Anti-Obesity Prescription Market Competition by Manufacturers
2.1 Global Anti-Obesity Prescription Sales Market Share by Manufacturers (2016-2021)
2.2 Global Anti-Obesity Prescription Revenue Market Share by Manufacturers (2016-2021)
2.3 Global Anti-Obesity Prescription Average Price by Manufacturers (2016-2021)
2.4 Manufacturers Anti-Obesity Prescription Manufacturing Sites, Area Served, Product Type
2.5 Anti-Obesity Prescription Market Competitive Situation and Trends
2.5.1 Anti-Obesity Prescription Market Concentration Rate
2.5.2 The Global Top 5 and Top 10 Largest Anti-Obesity Prescription Players Market Share by Revenue
2.5.3 Global Anti-Obesity Prescription Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.6 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Anti-Obesity Prescription Retrospective Market Scenario by Region
3.1 Global Anti-Obesity Prescription Retrospective Market Scenario in Revenue by Region: 2016-2021
3.2 Global Anti-Obesity Prescription Retrospective Market Scenario in Sales by Region: 2016-2021
3.3 North America Anti-Obesity Prescription Market Facts & Figures by Country
3.3.1 North America Anti-Obesity Prescription Sales by Country
3.3.2 North America Anti-Obesity Prescription Revenue by Country
3.3.3 U.S.
3.3.4 Canada
3.4 Europe Anti-Obesity Prescription Market Facts & Figures by Country
3.4.1 Europe Anti-Obesity Prescription Sales by Country
3.4.2 Europe Anti-Obesity Prescription Revenue by Country
3.4.3 Germany
3.4.4 France
3.4.5 U.K.
3.4.6 Italy
3.4.7 Russia
3.5 Asia Pacific Anti-Obesity Prescription Market Facts & Figures by Region
3.5.1 Asia Pacific Anti-Obesity Prescription Sales by Region
3.5.2 Asia Pacific Anti-Obesity Prescription Revenue by Region
3.5.3 China
3.5.4 Japan
3.5.5 South Korea
3.5.6 India
3.5.7 Australia
3.5.8 Taiwan
3.5.9 Indonesia
3.5.10 Thailand
3.5.11 Malaysia
3.5.12 Philippines
3.5.13 Vietnam
3.6 Latin America Anti-Obesity Prescription Market Facts & Figures by Country
3.6.1 Latin America Anti-Obesity Prescription Sales by Country
3.6.2 Latin America Anti-Obesity Prescription Revenue by Country
3.6.3 Mexico
3.6.4 Brazil
3.6.5 Argentina
3.7 Middle East and Africa Anti-Obesity Prescription Market Facts & Figures by Country
3.7.1 Middle East and Africa Anti-Obesity Prescription Sales by Country
3.7.2 Middle East and Africa Anti-Obesity Prescription Revenue by Country
3.7.3 Turkey
3.7.4 Saudi Arabia
3.7.5 U.A.E
4 Global Anti-Obesity Prescription Historic Market Analysis by Type
4.1 Global Anti-Obesity Prescription Sales Market Share by Type (2016-2021)
4.2 Global Anti-Obesity Prescription Revenue Market Share by Type (2016-2021)
4.3 Global Anti-Obesity Prescription Price by Type (2016-2021)
5 Global Anti-Obesity Prescription Historic Market Analysis by Application
5.1 Global Anti-Obesity Prescription Sales Market Share by Application (2016-2021)
5.2 Global Anti-Obesity Prescription Revenue Market Share by Application (2016-2021)
5.3 Global Anti-Obesity Prescription Price by Application (2016-2021)
6 Key Companies Profiled
6.1 Zydus Cadila
6.1.1 Zydus Cadila Corporation Information
6.1.2 Zydus Cadila Description and Business Overview
6.1.3 Zydus Cadila Anti-Obesity Prescription Sales, Revenue and Gross Margin (2016-2021)
6.1.4 Zydus Cadila Product Portfolio
6.1.5 Zydus Cadila Recent Developments/Updates
6.2 Akrimax Pharmaceuticals
6.2.1 Akrimax Pharmaceuticals Corporation Information
6.2.2 Akrimax Pharmaceuticals Description and Business Overview
6.2.3 Akrimax Pharmaceuticals Anti-Obesity Prescription Sales, Revenue and Gross Margin (2016-2021)
6.2.4 Akrimax Pharmaceuticals Product Portfolio
6.2.5 Akrimax Pharmaceuticals Recent Developments/Updates
6.3 Zealand Pharma
6.3.1 Zealand Pharma Corporation Information
6.3.2 Zealand Pharma Description and Business Overview
6.3.3 Zealand Pharma Anti-Obesity Prescription Sales, Revenue and Gross Margin (2016-2021)
6.3.4 Zealand Pharma Product Portfolio
6.3.5 Zealand Pharma Recent Developments/Updates
6.4 Arrowhead Research
6.4.1 Arrowhead Research Corporation Information
6.4.2 Arrowhead Research Description and Business Overview
6.4.3 Arrowhead Research Anti-Obesity Prescription Sales, Revenue and Gross Margin (2016-2021)
6.4.4 Arrowhead Research Product Portfolio
6.4.5 Arrowhead Research Recent Developments/Updates
6.5 Arena Pharmaceuticals
6.5.1 Arena Pharmaceuticals Corporation Information
6.5.2 Arena Pharmaceuticals Description and Business Overview
6.5.3 Arena Pharmaceuticals Anti-Obesity Prescription Sales, Revenue and Gross Margin (2016-2021)
6.5.4 Arena Pharmaceuticals Product Portfolio
6.5.5 Arena Pharmaceuticals Recent Developments/Updates
6.6 Compellis Pharmaceuticals
6.6.1 Compellis Pharmaceuticals Corporation Information
6.6.2 Compellis Pharmaceuticals Description and Business Overview
6.6.3 Compellis Pharmaceuticals Anti-Obesity Prescription Sales, Revenue and Gross Margin (2016-2021)
6.6.4 Compellis Pharmaceuticals Product Portfolio
6.6.5 Compellis Pharmaceuticals Recent Developments/Updates
6.7 Yungjin Pharm
6.6.1 Yungjin Pharm Corporation Information
6.6.2 Yungjin Pharm Description and Business Overview
6.6.3 Yungjin Pharm Anti-Obesity Prescription Sales, Revenue and Gross Margin (2016-2021)
6.4.4 Yungjin Pharm Product Portfolio
6.7.5 Yungjin Pharm Recent Developments/Updates
6.8 Alpex Pharma
6.8.1 Alpex Pharma Corporation Information
6.8.2 Alpex Pharma Description and Business Overview
6.8.3 Alpex Pharma Anti-Obesity Prescription Sales, Revenue and Gross Margin (2016-2021)
6.8.4 Alpex Pharma Product Portfolio
6.8.5 Alpex Pharma Recent Developments/Updates
6.9 Bridge BioResearch
6.9.1 Bridge BioResearch Corporation Information
6.9.2 Bridge BioResearch Description and Business Overview
6.9.3 Bridge BioResearch Anti-Obesity Prescription Sales, Revenue and Gross Margin (2016-2021)
6.9.4 Bridge BioResearch Product Portfolio
6.9.5 Bridge BioResearch Recent Developments/Updates
7 Anti-Obesity Prescription Manufacturing Cost Analysis
7.1 Anti-Obesity Prescription Key Raw Materials Analysis
7.1.1 Key Raw Materials
7.1.2 Key Suppliers of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
7.3 Manufacturing Process Analysis of Anti-Obesity Prescription
7.4 Anti-Obesity Prescription Industrial Chain Analysis
8 Marketing Channel, Distributors and Customers
8.1 Marketing Channel
8.2 Anti-Obesity Prescription Distributors List
8.3 Anti-Obesity Prescription Customers
9 Anti-Obesity Prescription Market Dynamics
9.1 Anti-Obesity Prescription Industry Trends
9.2 Anti-Obesity Prescription Growth Drivers
9.3 Anti-Obesity Prescription Market Challenges
9.4 Anti-Obesity Prescription Market Restraints
10 Global Market Forecast
10.1 Anti-Obesity Prescription Market Estimates and Projections by Type
10.1.1 Global Forecasted Sales of Anti-Obesity Prescription by Type (2022-2027)
10.1.2 Global Forecasted Revenue of Anti-Obesity Prescription by Type (2022-2027)
10.2 Anti-Obesity Prescription Market Estimates and Projections by Application
10.2.1 Global Forecasted Sales of Anti-Obesity Prescription by Application (2022-2027)
10.2.2 Global Forecasted Revenue of Anti-Obesity Prescription by Application (2022-2027)
10.3 Anti-Obesity Prescription Market Estimates and Projections by Region
10.3.1 Global Forecasted Sales of Anti-Obesity Prescription by Region (2022-2027)
10.3.2 Global Forecasted Revenue of Anti-Obesity Prescription by Region (2022-2027)
11 Research Finding and Conclusion
12 Methodology and Data Source
12.1 Methodology/Research Approach
12.1.1 Research Programs/Design
12.1.2 Market Size Estimation
12.1.3 Market Breakdown and Data Triangulation
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Author List
12.4 Disclaimer
List of Figures, Tables and Charts Available in Global Anti-Obesity Prescription Market Research Report 2021
List of TablesTable 1. Global Anti-Obesity Prescription Sales (K Pcs) Growth Rate Comparison by Type (2021-2027)
Table 2. Global Anti-Obesity Prescription Sales (K Pcs) Comparison by Application (2021-2027)
Table 3. Global Anti-Obesity Prescription Market Size by Region (US$ Million) (2016 VS 2021 VS 2027)
Table 4. Key Manufacturers Anti-Obesity Prescription Covered in This Study
Table 5. Global Anti-Obesity Prescription Sales (K Pcs) of Key Manufacturers (2016-2021)
Table 6. Global Anti-Obesity Prescription Sales Share by Manufacturers (2016-2021)
Table 7. Global Anti-Obesity Prescription Revenue (US$ Million) by Manufacturers (2016-2021)
Table 8. Global Anti-Obesity Prescription Revenue Share by Manufacturers (2016-2021)
Table 9. Global Market Anti-Obesity Prescription Average Price (USD/Pcs) of Key Manufacturers (2016-2021)
Table 10. Manufacturers Anti-Obesity Prescription Manufacturing Sites and Area Served
Table 11. Manufacturers Anti-Obesity Prescription Product Type
Table 12. Global Anti-Obesity Prescription Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 13. Global Anti-Obesity Prescription by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Anti-Obesity Prescription as of 2020)
Table 14. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 15. Global Anti-Obesity Prescription Sales by Region (2016-2021) & (K Pcs)
Table 16. Global Anti-Obesity Prescription Sales Market Share by Region (2016-2021)
Table 17. Global Anti-Obesity Prescription Revenue by Region (2016-2021) & (US$ Million)
Table 18. North America Anti-Obesity Prescription Sales by Country (2016-2021) & (K Pcs)
Table 19. North America Anti-Obesity Prescription Sales Market Share by Country (2016-2021)
Table 20. North America Anti-Obesity Prescription Revenue by Country (2016-2021) & (US$ Million)
Table 21. North America Anti-Obesity Prescription Revenue Market Share by Country (2016-2021)
Table 22. Europe Anti-Obesity Prescription Sales by Country (2016-2021) & (K Pcs)
Table 23. Europe Anti-Obesity Prescription Sales Market Share by Country (2016-2021)
Table 24. Europe Anti-Obesity Prescription Revenue by Country (2016-2021) & (US$ Million)
Table 25. Europe Anti-Obesity Prescription Revenue Market Share by Country (2016-2021)
Table 26. Asia Pacific Anti-Obesity Prescription Sales by Region (2016-2021) & (K Pcs)
Table 27. Asia Pacific Anti-Obesity Prescription Sales Market Share by Region (2016-2021)
Table 28. Asia Pacific Anti-Obesity Prescription Revenue by Region (2016-2021) & (US$ Million)
Table 29. Asia Pacific Anti-Obesity Prescription Revenue Market Share by Region (2016-2021)
Table 30. Latin America Anti-Obesity Prescription Sales by Country (2016-2021) & (K Pcs)
Table 31. Latin America Anti-Obesity Prescription Sales Market Share by Country (2016-2021)
Table 32. Latin America Anti-Obesity Prescription Revenue by Country (2016-2021) & (US$ Million)
Table 33. Latin America Anti-Obesity Prescription Revenue Market Share by Country (2016-2021)
Table 34. Middle East and Africa Anti-Obesity Prescription Sales by Country (2016-2021) & (K Pcs)
Table 35. Middle East and Africa Anti-Obesity Prescription Sales Market Share by Country (2016-2021)
Table 36. Middle East and Africa Anti-Obesity Prescription Revenue by Country (2016-2021) & (US$ Million)
Table 37. Middle East and Africa Anti-Obesity Prescription Revenue Market Share by Country (2016-2021)
Table 38. Global Anti-Obesity Prescription Sales (K Pcs) by Type (2016-2021)
Table 39. Global Anti-Obesity Prescription Sales Market Share by Type (2016-2021)
Table 40. Global Anti-Obesity Prescription Revenue (Million US$) by Type (2016-2021)
Table 41. Global Anti-Obesity Prescription Revenue Share by Type (2016-2021)
Table 42. Global Anti-Obesity Prescription Price (USD/Pcs) by Type (2016-2021)
Table 43. Global Anti-Obesity Prescription Sales (K Pcs) by Application (2016-2021)
Table 44. Global Anti-Obesity Prescription Sales Market Share by Application (2016-2021)
Table 45. Global Anti-Obesity Prescription Revenue (Million US$) by Application (2016-2021)
Table 46. Global Anti-Obesity Prescription Revenue Share by Application (2016-2021)
Table 47. Global Anti-Obesity Prescription Price (USD/Pcs) by Application (2016-2021)
Table 48. Zydus Cadila Corporation Information
Table 49. Zydus Cadila Description and Business Overview
Table 50. Zydus Cadila Anti-Obesity Prescription Sales (K Pcs), Revenue (Million US$), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 51. Zydus Cadila Anti-Obesity Prescription Product
Table 52. Zydus Cadila Recent Developments/Updates
Table 53. Akrimax Pharmaceuticals Corporation Information
Table 54. Akrimax Pharmaceuticals Description and Business Overview
Table 55. Akrimax Pharmaceuticals Anti-Obesity Prescription Sales (K Pcs), Revenue (Million US$), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 56. Akrimax Pharmaceuticals Anti-Obesity Prescription Product
Table 57. Akrimax Pharmaceuticals Recent Developments/Updates
Table 58. Zealand Pharma Corporation Information
Table 59. Zealand Pharma Description and Business Overview
Table 60. Zealand Pharma Anti-Obesity Prescription Sales (K Pcs), Revenue (Million US$), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 61. Zealand Pharma Anti-Obesity Prescription Product
Table 62. Zealand Pharma Recent Developments/Updates
Table 63. Arrowhead Research Corporation Information
Table 64. Arrowhead Research Description and Business Overview
Table 65. Arrowhead Research Anti-Obesity Prescription Sales (K Pcs), Revenue (Million US$), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 66. Arrowhead Research Anti-Obesity Prescription Product
Table 67. Arrowhead Research Recent Developments/Updates
Table 68. Arena Pharmaceuticals Corporation Information
Table 69. Arena Pharmaceuticals Description and Business Overview
Table 70. Arena Pharmaceuticals Anti-Obesity Prescription Sales (K Pcs), Revenue (Million US$), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 71. Arena Pharmaceuticals Anti-Obesity Prescription Product
Table 72. Arena Pharmaceuticals Recent Developments/Updates
Table 73. Compellis Pharmaceuticals Corporation Information
Table 74. Compellis Pharmaceuticals Description and Business Overview
Table 75. Compellis Pharmaceuticals Anti-Obesity Prescription Sales (K Pcs), Revenue (Million US$), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 76. Compellis Pharmaceuticals Anti-Obesity Prescription Product
Table 77. Compellis Pharmaceuticals Recent Developments/Updates
Table 78. Yungjin Pharm Corporation Information
Table 79. Yungjin Pharm Description and Business Overview
Table 80. Yungjin Pharm Anti-Obesity Prescription Sales (K Pcs), Revenue (Million US$), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 81. Yungjin Pharm Anti-Obesity Prescription Product
Table 82. Yungjin Pharm Recent Developments/Updates
Table 83. Alpex Pharma Corporation Information
Table 84. Alpex Pharma Description and Business Overview
Table 85. Alpex Pharma Anti-Obesity Prescription Sales (K Pcs), Revenue (Million US$), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 86. Alpex Pharma Anti-Obesity Prescription Product
Table 87. Alpex Pharma Recent Developments/Updates
Table 88. Bridge BioResearch Corporation Information
Table 89. Bridge BioResearch Description and Business Overview
Table 90. Bridge BioResearch Anti-Obesity Prescription Sales (K Pcs), Revenue (Million US$), Price (USD/Pcs) and Gross Margin (2016-2021)
Table 91. Bridge BioResearch Anti-Obesity Prescription Product
Table 92. Bridge BioResearch Recent Developments/Updates
Table 93. Production Base and Market Concentration Rate of Raw Material
Table 94. Key Suppliers of Raw Materials
Table 95. Anti-Obesity Prescription Distributors List
Table 96. Anti-Obesity Prescription Customers List
Table 97. Anti-Obesity Prescription Market Trends
Table 98. Anti-Obesity Prescription Growth Drivers
Table 99. Anti-Obesity Prescription Market Restraints
Table 100. Global Anti-Obesity Prescription Sales Forecast by Type (2022-2027) & (K Pcs)
Table 101. Global Anti-Obesity Prescription Sales Market Share Forecast by Type (2022-2027)
Table 102. Global Anti-Obesity Prescription Revenue Forecast by Type (2022-2027) & (US$ Million)
Table 103. Global Anti-Obesity Prescription Revenue Market Share Forecast by Type (2022-2027)
Table 104. Global Anti-Obesity Prescription Sales Forecast by Application (2022-2027) & (K Pcs)
Table 105. Global Anti-Obesity Prescription Sales Market Share Forecast by Application (2022-2027)
Table 106. Global Anti-Obesity Prescription Revenue Forecast by Application (2022-2027) & (US$ Million)
Table 107. Global Anti-Obesity Prescription Revenue Market Share Forecast by Application (2022-2027)
Table 108. Global Anti-Obesity Prescription Sales Forecast by Region (2022-2027) & (K Pcs)
Table 109. Global Anti-Obesity Prescription Sales Market Share Forecast by Region (2022-2027)
Table 110. Global Anti-Obesity Prescription Revenue Forecast by Region (2022-2027) & (US$ Million)
Table 111. Global Anti-Obesity Prescription Revenue Market Share Forecast by Region (2022-2027)
Table 112. Research Programs/Design for This Report
Table 113. Key Data Information from Secondary Sources
Table 114. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Anti-Obesity Prescription
Figure 2. Global Anti-Obesity Prescription Market Share by Type in 2020 & 2027
Figure 3. Bupropion and Naltrexone Product Picture
Figure 4. Orlistat Product Picture
Figure 5. Lorcaserin Product Picture
Figure 6. Phentermine and Topiramate Product Picture
Figure 7. Liraglutide Product Picture
Figure 8. Global Anti-Obesity Prescription Market Share by Application in 2020 & 2027
Figure 9. Hospital Pharmacies
Figure 10. Retail Pharmacies
Figure 11. E-Commerce
Figure 12. Global Anti-Obesity Prescription Revenue, (US$ Million), 2016 VS 2021 VS 2027
Figure 13. Global Anti-Obesity Prescription Market Size 2016-2027 (US$ Million)
Figure 14. Global Anti-Obesity Prescription Sales 2016-2027 (K Pcs)
Figure 15. Global Anti-Obesity Prescription Market Size Market Share by Region: 2016 VS 20210 VS 2027
Figure 16. Anti-Obesity Prescription Sales Share by Manufacturers in 2020
Figure 17. Global Anti-Obesity Prescription Revenue Share by Manufacturers in 2020
Figure 18. The Global 5 and 10 Largest Anti-Obesity Prescription Players: Market Share by Revenue in 2020
Figure 19. Anti-Obesity Prescription Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2016 VS 2021
Figure 20. Global Anti-Obesity Prescription Sales Market Share by Region (2016-2021)
Figure 21. Global Anti-Obesity Prescription Sales Market Share by Region in 2020
Figure 22. Global Anti-Obesity Prescription Revenue Market Share by Region (2016-2021)
Figure 23. Global Anti-Obesity Prescription Revenue Market Share by Region in 2020
Figure 24. U.S. Anti-Obesity Prescription Revenue Growth Rate (2016-2021) (US$ Million)
Figure 25. Canada Anti-Obesity Prescription Revenue Growth Rate (2016-2021) (US$ Million)
Figure 26. Germany Anti-Obesity Prescription Revenue Growth Rate (2016-2021) (US$ Million)
Figure 27. France Anti-Obesity Prescription Revenue Growth Rate (2016-2021) (US$ Million)
Figure 28. U.K. Anti-Obesity Prescription Revenue Growth Rate (2016-2021) (US$ Million)
Figure 29. Italy Anti-Obesity Prescription Revenue Growth Rate (2016-2021) (US$ Million)
Figure 30. Russia Anti-Obesity Prescription Revenue Growth Rate (2016-2021) (US$ Million)
Figure 31. China Anti-Obesity Prescription Revenue Growth Rate (2016-2021) (US$ Million)
Figure 32. Japan Anti-Obesity Prescription Revenue Growth Rate (2016-2021) (US$ Million)
Figure 33. South Korea Anti-Obesity Prescription Revenue Growth Rate (2016-2021) (US$ Million)
Figure 34. India Anti-Obesity Prescription Revenue Growth Rate (2016-2021) (US$ Million)
Figure 35. Australia Anti-Obesity Prescription Revenue Growth Rate (2016-2021) (US$ Million)
Figure 36. Taiwan Anti-Obesity Prescription Revenue Growth Rate (2016-2021) (US$ Million)
Figure 37. Indonesia Anti-Obesity Prescription Revenue Growth Rate (2016-2021) (US$ Million)
Figure 38. Thailand Anti-Obesity Prescription Revenue Growth Rate (2016-2021) (US$ Million)
Figure 39. Malaysia Anti-Obesity Prescription Revenue Growth Rate (2016-2021) (US$ Million)
Figure 40. Philippines Anti-Obesity Prescription Revenue Growth Rate (2016-2021) (US$ Million)
Figure 41. Vietnam Anti-Obesity Prescription Revenue Growth Rate (2016-2021) (US$ Million)
Figure 42. Mexico Anti-Obesity Prescription Revenue Growth Rate (2016-2021) (US$ Million)
Figure 43. Brazil Anti-Obesity Prescription Revenue Growth Rate (2016-2021) (US$ Million)
Figure 44. Argentina Anti-Obesity Prescription Revenue Growth Rate (2016-2021) (US$ Million)
Figure 45. Turkey Anti-Obesity Prescription Revenue Growth Rate (2016-2021) (US$ Million)
Figure 46. Saudi Arabia Anti-Obesity Prescription Revenue Growth Rate (2016-2021) (US$ Million)
Figure 47. U.A.E Anti-Obesity Prescription Revenue Growth Rate (2016-2021) (US$ Million)
Figure 48. Sales Market Share of Anti-Obesity Prescription by Type (2016-2021)
Figure 49. Sales Market Share of Anti-Obesity Prescription by Application (2016-2021)
Figure 50. Sales Market Share of Anti-Obesity Prescription by Application in 2020
Figure 51. Revenue Share of Anti-Obesity Prescription by Application (2016-2021)
Figure 52. Revenue Share of Anti-Obesity Prescription by Application in 2020
Figure 53. Manufacturing Cost Structure of Anti-Obesity Prescription
Figure 54. Manufacturing Process Analysis of Anti-Obesity Prescription
Figure 55. Anti-Obesity Prescription Industrial Chain Analysis
Figure 56. Channels of Distribution
Figure 57. Distributors Profiles
Figure 58. Bottom-up and Top-down Approaches for This Report
Figure 59. Data Triangulation
Figure 60. Key Executives Interviewed
Keyplayers in Global Anti-Obesity Prescription Market Research Report 2021
Zydus CadilaAkrimax Pharmaceuticals
Zealand Pharma
Arrowhead Research
Arena Pharmaceuticals
Compellis Pharmaceuticals
Yungjin Pharm
Alpex Pharma
Bridge BioResearch
Request Sample
Request Discount
